Hologic presents new DR units
Bone densitometry company Hologic introduced two new digital general radiography systems this month at the RSNA show. Epex and Radex are based on DirectRay solid-state electronic and semiconductor technologies to capture x-rays. Epex is a high-end unit,
Bone densitometry company Hologic introduced two new digital general radiography systems this month at the RSNA show. Epex and Radex are based on DirectRay solid-state electronic and semiconductor technologies to capture x-rays. Epex is a high-end unit, while Radex is a simpler system designed for the outpatient market. Both units will be installed in clinical facilities during the second quarter of 2000.
The two new units round out the Bedford, MA, companys product line, which also includes its DR1000C digital chest system and DR1000 general radiography system. DR1000C units have been installed in five European countries, as well as at sites in Canada and the U.S., and Hologic made its first clinical installations of DR1000 in November.
In other Hologic news, the firm has established a new organizational structure for bringing its systems to market: Hologic will design, market, and service its radiographic products, while its subsidiary, Direct Radiography Corp. (DRC), will be responsible for designing, manufacturing, and servicing DirectRay detectors. DRC will market the detectors as fully integrated Hologic radiographic systems, as a digital image capture upgrade for existing x-ray equipment sold through distributors, and as a component for OEMs.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
